Why Participate in a Clinical Trial?

As the understanding of cancer biology continues to evolve, we continue to improve cancer care through the introduction of new and better “targeted” drugs. Currently, there are more cancer drugs being developed than at any time in human history, due to better understanding of cancer biology and the promise of personalized medicine. Since we are still unable to cure a majority of metastatic (stage IV) cancers, there is arguably always room for improvement in the current standard of care. The only way to improve the current standard of care is by patients participating in clinical trials to improve this current standard. Currently only 2-3 percent of all cancer patients nationwide participate in clinical trials. If more patients were to participate in clinical trials, we would be able to improve cancer care at a substantially faster rate for the future generations to come. Also, participating in clinical trials allows patients the chance to receive treatment with a drug that might otherwise not be available for many years to come.

Choosing to participate in a clinical trial is an important personal decision. Make sure to meet with your doctor to discuss both current treatment options and clinical trial options.

Search Our Clinical Trials at START Midwest

Interested in learning more about the trials at START? Select a preferred START location to find out more.